Concepedia

Publication | Closed Access

The management of anti-tuberculosis drug-induced hepatotoxicity.

103

Citations

0

References

2001

Year

Kemal Tahaoğlu, G Ataç, Tülin Sevim, Tushar Tarun, Gülbanu Horzum, I Gemci, A Ongel, Emine Aksoy
PubMed

Abstract

The recurrence rate of hepatotoxicity in the retreatment of tuberculosis is higher in the reintroduction of a full-dose regimen including pyrazinamide, which causes more hepatotoxicity than gradual reintroduction of a regimen without pyrazinamide.